Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
20 studies found for:    "Ehlers-Danlos syndrome"
Show Display Options
Rank Status Study
1 Completed Obstructive Sleep Apnoea in Ehlers-Danlos Syndrome
Conditions: Ehlers-Danlos Syndrome;   Obstructive Sleep Apnea
2 Completed Mind-Body Therapy for Pain in Ehlers-Danlos Syndrome
Conditions: Ehlers-Danlos Syndrome;   Pain
Intervention: Drug: Mind-body therapy
3 Recruiting Obstructive Sleep Apnoea in Children and Adolescents With Ehlers-Danlos Syndrome
Conditions: Ehler's Danlos Syndrome;   Obstructive Sleep Apnea
Intervention: Other: No intervention
4 Completed Biomarkers in Vascular Ehlers-Danlos Syndrome
Condition: Vascular Ehlers-Danlos Syndrome
5 Completed Head Circumference Growth in Children With Ehlers-Danlos Syndrome Who Develop Dysautonomia Later in Life
Conditions: Ehlers Danlos Syndrome;   External Hydrocephalus;   Dysautonomia;   Postural Orthostatic Tachycardia Syndrome;   Venous Insufficiency
6 Completed Celiprolol in Patients With Ehlers-Danlos Syndrome, Vascular Type
Interventions: Drug: celiprolol;   Drug: Control
7 Recruiting Angiotensin II Receptor Blockade in Vascular Ehlers Danlos Syndrome (ARCADE)
Condition: Ehlers-Danlos Syndrome, Vascular Type
Interventions: Drug: Irbesartan;   Drug: Placebo
8 Recruiting Wearing a Compression Garment for Patients With Hypermobility Type of Ehlers-Danlos Syndrome
Condition: Ehlers-Danlos Syndrome Hypermobility Type
Intervention: Device: short-sleeved vest CICATREX SED®)
9 Completed Patient Education Program and Ehlers-Danlos Syndrome
Condition: Hypermobility Type Ehlers-Danlos Syndrome
Intervention: Other: patient education program
10 Enrolling by invitation Riboflavin Corneal Crosslinking for Brittle Cornea Syndrome and Ehlers-Danlos Syndrome Type VI
Conditions: Brittle Cornea Syndrome;   Ehlers-Danlos Syndrome Type 6
Interventions: Drug: Riboflavin;   Device: Kera-X
11 Completed Vascular Fundus Changes in Patients With High Probability of Chronic Cerebrospinal Venous Insufficiency (CCSVI)
Conditions: Ehlers-Danlos Syndrome;   Multiple Sclerosis
12 Active, not recruiting National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions
Conditions: Marfan Syndrome;   Turner Syndrome;   Ehlers-Danlos Syndrome;   Loeys-Dietz Syndrome;   FBN1, TGFBR1, TGFBR2, ACTA2 or MYH11 Genetic Mutation;   Bicuspid Aortic Valve Without Known Family History;   Bicuspid Aortic Valve With Family History;   Bicuspid Aortic Valve With Coarctation;   Familial Thoracic Aortic Aneurysm and Dissections;   Shprintzen-Goldberg Syndrome;   Other Aneur/Diss of Thoracic Aorta Not Due to Trauma, <50yo;   Other Congenital Heart Disease
13 Completed Studies of Heritable Disorders of Connective Tissue
Conditions: Ehlers-Danlos Syndrome;   Stickler Syndrome;   Marfan Syndrome
14 Completed Study of Heritable Connective Tissue Disorders
Conditions: Connective Tissue Disease;   Dissecting Aneurysm;   Ehlers Danlos Syndrome;   Marfan Syndrome;   Nail Patella Syndrome
15 Not yet recruiting Origins and Impact of EDS in Connective Tissues and Skin
Condition: Ehlers-Danlos Syndrome
Intervention: Procedure: Orthopaedic & Gynaecology surgery
16 Completed IGF-I Stimulation of Collagen Synthesis in Ehlers-Danlos Patients
Condition: Ehlers-Danlos Syndrome, Classic
Interventions: Drug: mecasermin;   Drug: Saline
17 Completed Non-Invasive Quantitative Imaging of Human Local Arterial Wall Elasticity Using Supersonic Shear Imaging
Conditions: Healthy Volunteers;   Vascular Ehlers Danlos Syndrome
Intervention: Other: SSI and SphygmoCor® evaluations
18 Recruiting The Comorbidity of Benign Hypermobility Joint Syndrome and Functional Constipation in Children
Conditions: Benign Hypermobility Syndrome;   Functional Constipation
19 Recruiting Investigation of Hypermobility, Biomarkers, and Pain Generators in Chronic Pain Patients
Conditions: Low Back Pain, Mechanical;   Spinal Stenosis;   Nerve Root Disorder;   Radiculopathy, Cervical;   Benign Hypermobility Syndrome
Intervention: Other: Beighton score for hypermobility
20 Recruiting Molecular Bases of Response to Copper Treatment in Menkes Disease, Related Phenotypes, and Unexplained Copper Deficiency
Conditions: Menkes Disease;   Occipital Horn Syndrome
Intervention: Drug: Copper Histidine

Indicates status has not been verified in more than two years